NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » SoniVie wins FDA breakthrough designation for TIVUS system to treat hypertensive disorders » Image – 1

SoniVie wins FDA breakthrough designation for TIVUS system to treat hypertensive disorders

NS Medical Devices is using cookies

US Food and Drug Administration regional office in Jamaica, Queens, NY. (Credit: CaptJayRuffins/Wikipedia.)

Related Article

Geko: How the DVT prevention device was developed and improved over its lifecycle

RECOMMENDED COMPANIES

MOST READ

Geko: How the DVT prevention device was developed and improved over its lifecycle

How have lockdowns and social distancing impacted the way medical device manufacturers are regulated?

A new rapid DNA test could predict which Covid-19 patients will need ICU care

The increased importance of supporting decentralised clinical trials during, and after, Covid-19

CES 2021: Five of the best medical technologies from this year’s innovation trade show

Recommended Whitepaper